All fields are mandatory.
Write a number from 1 (worst) to 5 (best) in the box below each item according to your degree of satisfaction.
Time Given for Presentations
Time Given for Discussions
Scientific Interaction with Speakers
Material Provided to the Students
Overall Course Organization
Communication before the Meeting
All fields are mandatory.
EVALUATION OF SCIENTIFIC ACTIVITIES
(rank 1-worse to 5-best)
Session 1: Introduction to LSDs - Monday – Oct 17 (morning)
1 - Cell Biology and Biochemistry of Lysosomes - Guilherme Baldo
2 - Pathophysiology of LSDs – Raphael Schiffmann
3 - Clinical Overview of LSDs - Gregory Pastores
4 - Genetic Aspects and Molecular Diagnosis of LSDs – Luis Figuera
Session 2: Gaucher Disease – Monday - Oct 17 (afternoon)
1 - Clinical Aspects of Gaucher Disease – Gregory Pastores
2 - Biochemical and genetic diagnosis of Gaucher Disease
Paula Rozenfeld
3 - Gaucher Disease: Management and Follow-up - Gregory Pastores
Session 3: Pompe Disease – Monday- Oct 17 (afternoon)
1 - Pompe Disease: Clinical Aspects, Management and Follow up - Hernan Amartino
2 - Biochemical and Genetic Diagnosis of Pompe Disease
Maira Burin & Francyne Kubaski
Session 5: Fabry Disease – Tuesday Oct 18 (morning)
1 - Fabry Disease: Clinical Aspects, Management and Follow up
Raphael Schiffmann
2 -Biochemical and Genetic Diagnosis of Fabry Disease
Maira Burin & Francyne Kubaski
Session 6: Gangliosidosis – Tuesday Oct 18 (morning)
1 - GM1 and GM2 Gangliosidosis: Clinical Aspects and Management - Hernan Amartino
2 - Gene Therapy for GM1 gangliosidosis and other neurodegenerative diseases - David Weinstein
Session 7: Mucopolysaccharidoses – Tuesday Oct 18 (Afternoon)
1 - Clinical Aspects of MPS - Joseph Muenzer
2 - Alpha-Mannosidosis and Glycoproteinoses - Joseph Muenzer
3 - Biochemical and Genetic Diagnosis of MPS and Glycoproteinoses - Maira Burin & Francyne Kubaski
4- Treatment for MPS: Approved Therapies - Roberto Giugliani
5 - Treatment for MPS: New Therapies - Joseph Muenzer
Session 8: Other LSDs – Wednesday - Oct 19 (Morning)
1 - Niemann-Pick type C and Defects of Lysosomal Membrane
Marie Vanier
2 - Neurodegeneration and Leukodystrophies - Hernan Amartino
3 - Acid Sphingomyelinase Deficiency: Clinical Aspects and
Management - Marie Vanier
4 - Newborn screening for LSDs - Roberto Giugliani
Session 10: Wrap‐Up – Thursday - Oct 20 (Afternoon)
1 - Inflammation and LSDs - Paula Rozenfeld
2 - Hematopoietic Stem Cell Transplantation in LSDs - Carmem Bonfim
3 - Diagnosis of LSDs in the Genomic Era - Filippo Vairo
4 - Genome Editing - Guilherme Baldo
5 - Gene Therapy and Future Prospects - Raphael Schiffmann
